I’m not sure which is better or worse: having a disability that is so visible that people stare at you in the street or one that is so invisible that people don’t believe you and accuse you of faking it.
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
Melbourne is coming out of its second COVID-19 lockdown and my feelings about this are mixed. What Will My Post-Lockdown Life Be Like With Chronic Illness?
I’ll tell you this much: Quarantining for the second time is much harder than the first.
If you are living with rheumatoid or other inflammatory arthritis, systemic lupus erythematosus and other autoimmune diseases, please take a moment to read this important information from the Australian Rheumatology Association (ARA) regarding COVID-19.
With new face mask regulations in Victoria, more hotspots in NSW and eased restrictions elsewhere, knowing when and where to wear a face mask can be tricky.
Jealousy is one of the seven deadly sins, but it feels justified in these, ahem, unprecedented times.
Do you use a biologic medication for your inflammatory arthritis? Do you know about biosimilars? Discover the basics as part of Biosimilar Awareness Week.
Axial spondyloarthritis (including ankylosing spondylitis) is a common form of arthritis, yet most Australians haven’t heard of it. CreakyJoints Australia would like to help change that.
Upadacitinib (Rinvoq®) is a new treatment option now available for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.